Journal article · 2008 · Open access

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease

William A. Banks

BMC Neuroscience, 9(S3), S2 · Published 1 December 2008 · DOI 10.1186/1471-2202-9-s3-s2

Open PDFView at the publisherCite this paper

In brief

“Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease” is a 2008 journal article by William A. Banks, published in BMC Neuroscience. OpenAlex counts 56 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at BMC Neuroscience.

Citations
56
Most cited in
2018 (5)
Field-weighted impact
1.74
References
10
Authors
1

Abstract

Development of therapeutics for the central nervous system is one of the most challenging areas in drug development. This is primarily because, in addition to all of the other complications one faces in developing new drugs targeting peripheral sites, one must also negotiate the blood-brain barrier (BBB). There are dozens of strategies to overcome the obstacle of the BBB, but many of these are bound to fail, barring extreme serendipity, because they are based on an inaccurate or incomplete picture of the BBB. This article therefore starts with a brief review of the BBB as it pertains to drug development. It then examines some examples of the delivery of drugs to the central nervous system that are relevant to Alzheimer's disease, placing emphasis on peptides, antibodies, and antisense oligonucleotides.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Banks, W. A. (2008). Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. BMC Neuroscience, 9(S3), S2. https://doi.org/10.1186/1471-2202-9-s3-s2

MLA 9

Banks, William A. “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.” BMC Neuroscience, vol. 9, no. S3, 2008, p. S2. https://doi.org/10.1186/1471-2202-9-s3-s2.

Chicago

Banks, William A. 2008. “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.” BMC Neuroscience 9 (S3): S2. https://doi.org/10.1186/1471-2202-9-s3-s2.

Harvard

Banks, W. A. (2008) ‘Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease’, BMC Neuroscience, 9(S3), p. S2. doi:10.1186/1471-2202-9-s3-s2.

IEEE

W. A. Banks, “Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease,” BMC Neuroscience, vol. 9, no. S3, p. S2, 2008, doi: 10.1186/1471-2202-9-s3-s2.

BibTeX

@article{banks2008developing,
  title     = {{Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease}},
  author    = {Banks, William A.},
  journal   = {BMC Neuroscience},
  year      = {2008},
  volume    = {9},
  number    = {S3},
  pages     = {S2},
  doi       = {10.1186/1471-2202-9-s3-s2},
  url       = {https://doi.org/10.1186/1471-2202-9-s3-s2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201422
201522
201733
201855
201933
202011
202155
202255
202322
202455

Its field-weighted citation impact is 1.74: it has been cited 1.74 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies

  • blood-brain barrier
  • Alzheimer's disease
  • brain drug delivery
  • blood-brain barrier permeability
  • peptides
  • immunoglobulins
  • antisense oligonucleotides

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Banks, W. A. (2008). Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. BMC Neuroscience, 9(S3), S2. https://doi.org/10.1186/1471-2202-9-s3-s2

How many times has this paper been cited?

56 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at BMC Neuroscience: sign in and open the PDF from this page.

Who wrote this paper?

William A. Banks.

What is the DOI of this paper?

10.1186/1471-2202-9-s3-s2, permanently at https://doi.org/10.1186/1471-2202-9-s3-s2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.